Viridian Therapeutics, Inc.\DE (VRDN) Non Operating Interest Expenses (2013 - 2026)
Viridian Therapeutics, Inc.\DE's Non Operating Interest Expenses was $8.31 million in Q2 2026, compared with $514,000 a year earlier and up 139.9% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Viridian Therapeutics, Inc.\DE's Non Operating Interest Expenses was $15.61 million through Jun 30, 2026, up 639.9% year-over-year; for FY2025, it was $4.95 million, up 125.2% from FY2024.
- Non Operating Interest Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 57.7% (FY2020 to FY2025).
- In earlier years, Non Operating Interest Expenses was $2.2 million in FY2024 (+65.1%), $1.33 million in FY2023 (+173.9%), $486,000 in FY2022 and $3,000 in FY2021 (-99.4%).
- The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses in data going back to Q2 2013.
- Compared with a year earlier, Non Operating Interest Expenses was higher in four of the last seven quarters, with growth averaging 152.5%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2025 (growth of 534.8%); the worst was Q4 2021 (a decline of 98.3%).
- Per Business Quant data, VRDN's Non Operating Interest Expenses in the three quarters before Q2 2026 was $3.46 million (Q1 2026), $3.28 million (Q4 2025) and $560,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | 8.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.31 Mn |
| Mar 31, 2026 | 3.46 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Dec 31, 2024 | 517,000.00 |
| Sep 30, 2024 | 529,000.00 |
| Jun 30, 2024 | 597,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Dec 31, 2022 | 168,000.00 |
| Sep 30, 2022 | 164,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 180,000.00 |
| Sep 30, 2020 | 93,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();